Developer docs
API playgroundTry for free, no card

Search company profiles

Deep Lens

Full company profile

uuid0005h8z

Namestring
Deep Lens
Websiteurl
deeplens.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Deep Lens, operating commercially as Paradigm Health, is a U.S.-based healthcare technology company founded in 2017 and headquartered in Columbus, Ohio. The company builds an intelligent research platform that connects patients, healthcare providers, and clinical trial sponsors with the goal of accelerating patient recruitment into oncology and other clinical trials, addressing the industry-wide problem that roughly 80% of drugs fail to meet enrollment targets. The platform combines technology and services, integrating directly with healthcare provider organizations so that clinical research capabilities are embedded into routine patient care workflows rather than operated as a separate sponsor-centric function.

The platform is organized as a multi-product suite spanning protocol optimization, feasibility and site selection, patient identification and enrollment acceleration, trial data capture and delivery, and a post-approval/late-stage clinical evidence platform oriented toward community care providers. Differentiation is described in terms of integration and interoperability with provider organizations, accuracy and precision in patient matching, and the ability to support a single site across multiple sponsors and trial phases. The core customer-facing outcomes demonstrated to date include a 45% increase in clinical trial patient enrollment over two years at reference customer Highlands Oncology, alongside reduced research-department burden.

The business model is subscription-based, with revenue generated from both trial sponsors (protocol optimization, feasibility, enrollment, data collection services) and healthcare provider research sites (integration services and research department enablement). Go-to-market is a direct enterprise sales motion with consultative, solution-selling engagement across both constituencies, supplemented by content marketing, LinkedIn presence, email newsletters, and participation in industry events. The company has disclosed approximately $17.2 million across two funding rounds — a $3.2M seed in September 2018 and a $14.0M Series A in April 2019 led by Northpond Ventures and Sierra Ventures — and operates with 11-50 employees.

Short descriptiontext

Deep Lens (operating as Paradigm Health) is a Columbus, Ohio-based healthcare technology company that operates an intelligent clinical trial recruitment and research platform connecting patients, providers, and trial sponsors to accelerate oncology trial enrollment.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersColumbus, United States
HQ citystring
Columbus
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient identification platform, oncology clinical research, trial site optimization, clinical research software
Industry2 codes
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
SECONDARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Trial Technology
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Services for Sponsors
TypeSubscription Recurring
Description

Technology and services platform connecting sponsors with research sites for clinical trial management, patient recruitment, and data collection

paradigmhealth.ai
2Provider Integration Services
TypeSubscription Recurring
Description

Integration services with healthcare provider organizations enabling clinical research capabilities

paradigmhealth.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Deep Lens (now operating as Paradigm Health) provides an AI-powered clinical trial recruitment and patient identification platform. The company matches patients to oncology and other clinical trials by integrating with electronic health record (EHR) data at research sites, enabling sponsors and sites to accelerate enrollment, optimize protocol design, and improve feasibility assessment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 45% increase in clinical trial patient enrollment over two years
+1 more record
Product and service6 records
1Protocol Optimization
CategoryClinical Trial Design
2Feasibility & Site Selection
CategoryClinical Trial Planning
3Patient Identification & Enrollment Acceleration
CategoryPatient Recruitment
4Trial Data Collection & Delivery
CategoryClinical Data Management
5Post-Approval and Late-Stage Clinical Evidence
CategoryReal-World Evidence
6Solutions For Research Sites
CategorySite Operations
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Customer case study partner demonstrating 45% increase in patient enrollment and reduced research burden. Highlands Oncology serves as a reference customer and proof point for Paradigm Health's platform effectiveness in oncology research settings.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Deep 6 AI
TypeDirect peer
Description

AI-driven patient identification and clinical trial matching platform that integrates with EHR systems to accelerate oncology and specialty trial recruitment; the closest direct peer to Deep Lens/Paradigm Health in mission, customer base, and technology approach.

2Mendel
TypeDirect peer
Description

AI platform that structures EMR data and matches patients to clinical trials and real-world evidence cohorts; competes directly with Deep Lens in serving sponsors and provider research sites for protocol-level patient feasibility.

TypeDirect peer
Description

AI-based clinical trial patient identification and cohort discovery platform integrated with major EHRs (e.g., Epic, Cerner); directly comparable to Deep Lens in serving community oncology and health system research sites.

TypeDirect peer
Description

AI-powered clinical trial matching focused on oncology, connecting patients and providers to trials through a virtual research site model; overlaps directly with Deep Lens on oncology patient recruitment use cases.

TypeBroad incumbent
Description

Largest CRO and clinical-tech incumbent offering EDC, feasibility, site selection, and patient recruitment within its broader services portfolio; sets the competitive reference for sponsors evaluating point solutions like Deep Lens.

TypeBroad incumbent
Description

Leading clinical trial data capture and analytics platform with patient-centric trial modules; competes for sponsor budgets on EDC, eCOA, and trial data collection where Deep Lens also plays.

TypeBroad incumbent
Description

Enterprise cloud platform for life sciences with Vault CTMS, EDC, and trial operations; comparable incumbent vendor competing for sponsor clinical technology wallet share relevant to Deep Lens.

TypeEmerging player
Description

Technology-enabled network of community oncology sites for trial recruitment and real-world research; overlaps with Deep Lens on community-site oncology trial enablement.

9Antidote (Trial Library acquisition lineage)
TypeEmerging player
Description

Patient-facing clinical trial matching platform historically focused on consumer-driven recruitment; relevant adjacent peer in the patient-trial matching category.

TypeBroad incumbent
Description

Global health research network providing real-world data and protocol feasibility for clinical trials; overlaps with Deep Lens on the sponsor-side feasibility and cohort query use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Deep Lens

Clinical Trial Technologydeeplens.ai

Deep Lens (operating as Paradigm Health) is a Columbus, Ohio-based healthcare technology company that operates an intelligent clinical trial recruitment and research platform connecting patients, providers, and trial sponsors to accelerate oncology trial enrollment.

What Deep Lens does

Deep Lens, operating commercially as Paradigm Health, is a U.S.-based healthcare technology company founded in 2017 and headquartered in Columbus, Ohio. The company builds an intelligent research platform that connects patients, healthcare providers, and clinical trial sponsors with the goal of accelerating patient recruitment into oncology and other clinical trials, addressing the industry-wide problem that roughly 80% of drugs fail to meet enrollment targets. The platform combines technology and services, integrating directly with healthcare provider organizations so that clinical research capabilities are embedded into routine patient care workflows rather than operated as a separate sponsor-centric function.

The platform is organized as a multi-product suite spanning protocol optimization, feasibility and site selection, patient identification and enrollment acceleration, trial data capture and delivery, and a post-approval/late-stage clinical evidence platform oriented toward community care providers. Differentiation is described in terms of integration and interoperability with provider organizations, accuracy and precision in patient matching, and the ability to support a single site across multiple sponsors and trial phases. The core customer-facing outcomes demonstrated to date include a 45% increase in clinical trial patient enrollment over two years at reference customer Highlands Oncology, alongside reduced research-department burden.

The business model is subscription-based, with revenue generated from both trial sponsors (protocol optimization, feasibility, enrollment, data collection services) and healthcare provider research sites (integration services and research department enablement). Go-to-market is a direct enterprise sales motion with consultative, solution-selling engagement across both constituencies, supplemented by content marketing, LinkedIn presence, email newsletters, and participation in industry events. The company has disclosed approximately $17.2 million across two funding rounds — a $3.2M seed in September 2018 and a $14.0M Series A in April 2019 led by Northpond Ventures and Sierra Ventures — and operates with 11-50 employees.

Deep Lens firmographics

Firmographics
Name
Deep Lens
Website
https://deeplens.ai
Company type
Private
Founded year
2017
Headcount range
1–10 employees
Short description
Deep Lens (operating as Paradigm Health) is a Columbus, Ohio-based healthcare technology company that operates an intelligent clinical trial recruitment and research platform connecting patients, providers, and trial sponsors to accelerate oncology trial enrollment.
Ownership category
akta.pro rank

Deep Lens industry classification

Industry
Product category
Clinical Trial Technology
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
SECONDARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)

Keywords

  • Clinical trial recruitment
  • Patient identification platform
  • Oncology clinical research
  • Trial site optimization
  • Clinical research software

Where Deep Lens is headquartered

Location

Headquarters

HQ city
Columbus
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Deep Lens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Platform Services for Sponsors: Technology and services platform connecting sponsors with research sites for clinical trial management, patient recruitment, and data collection
  2. Provider Integration Services: Integration services with healthcare provider organizations enabling clinical research capabilities

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Deep Lens product offering

Product offering

Core offering

Deep Lens (now operating as Paradigm Health) provides an AI-powered clinical trial recruitment and patient identification platform. The company matches patients to oncology and other clinical trials by integrating with electronic health record (EHR) data at research sites, enabling sponsors and sites to accelerate enrollment, optimize protocol design, and improve feasibility assessment.

Differentiator

Problem solved

Functional benefit

Products and services

  • Protocol Optimization
  • Feasibility & Site Selection
  • Patient Identification & Enrollment Acceleration
  • Trial Data Collection & Delivery
  • Post-Approval and Late-Stage Clinical Evidence
  • Solutions For Research Sites

Quantifiable outcome

  • 45% increase in clinical trial patient enrollment over two years
  • +1 more outcomes

Companies that use Deep Lens

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Deep Lens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Deep Lens partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Highlands OncologycoreStrategic or Co-development PartnerCustomer case study partner demonstrating 45% increase in patient enrollment and reduced research burden. Highlands Oncology serves as a reference customer and proof point for Paradigm Health's platform effectiveness in oncology research settings.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Deep Lens competitors and assessment

Company assessment

Direct peers

  • Deep 6 AI: AI-driven patient identification and clinical trial matching platform that integrates with EHR systems to accelerate oncology and specialty trial recruitment; the closest direct peer to Deep Lens/Paradigm Health in mission, customer base, and technology approach.
  • Mendel: AI platform that structures EMR data and matches patients to clinical trials and real-world evidence cohorts; competes directly with Deep Lens in serving sponsors and provider research sites for protocol-level patient feasibility.
  • BEKhealth: AI-based clinical trial patient identification and cohort discovery platform integrated with major EHRs (e.g., Epic, Cerner); directly comparable to Deep Lens in serving community oncology and health system research sites.
  • Massive Bio: AI-powered clinical trial matching focused on oncology, connecting patients and providers to trials through a virtual research site model; overlaps directly with Deep Lens on oncology patient recruitment use cases.

Broad incumbents

  • IQVIA (Orchestrated Patient Engagement / E360): Largest CRO and clinical-tech incumbent offering EDC, feasibility, site selection, and patient recruitment within its broader services portfolio; sets the competitive reference for sponsors evaluating point solutions like Deep Lens.
  • Medidata (Dassault Systèmes): Leading clinical trial data capture and analytics platform with patient-centric trial modules; competes for sponsor budgets on EDC, eCOA, and trial data collection where Deep Lens also plays.
  • Veeva Systems: Enterprise cloud platform for life sciences with Vault CTMS, EDC, and trial operations; comparable incumbent vendor competing for sponsor clinical technology wallet share relevant to Deep Lens.
  • TriNetX: Global health research network providing real-world data and protocol feasibility for clinical trials; overlaps with Deep Lens on the sponsor-side feasibility and cohort query use cases.

Emerging players

  • Trial Library: Technology-enabled network of community oncology sites for trial recruitment and real-world research; overlaps with Deep Lens on community-site oncology trial enablement.
  • Antidote (Trial Library acquisition lineage): Patient-facing clinical trial matching platform historically focused on consumer-driven recruitment; relevant adjacent peer in the patient-trial matching category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Deep Lens social profiles

Digital presence

Deep Lens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Deep Lens leadership team

Management profile

Number of profiles

Profiles2 records

Deep Lens funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Deep Lens M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deep Lens

What does Deep Lens do?

Deep Lens (now operating as Paradigm Health) provides an AI-powered clinical trial recruitment and patient identification platform. The company matches patients to oncology and other clinical trials by integrating with electronic health record (EHR) data at research sites, enabling sponsors and sites to accelerate enrollment, optimize protocol design, and improve feasibility assessment.

When was Deep Lens founded?

Deep Lens was founded in 2017. It employs 1 to 10 people.

Where is Deep Lens based?

Deep Lens is headquartered in Columbus, United States, in the North America region.

How does Deep Lens make money?

Two revenue lines are on record. Platform Services for Sponsors are the primary driver. The others are provider Integration Services.

Who are Deep Lens's main competitors?

Direct peers on record are Deep 6 AI, Mendel, BEKhealth and Massive Bio. Broad incumbents are IQVIA (Orchestrated Patient Engagement / E360), Medidata (Dassault Systèmes), Veeva Systems and TriNetX. Emerging players are Trial Library and Antidote (Trial Library acquisition lineage).

Does Deep Lens have an API?

No public API is recorded for Deep Lens.

What industry is Deep Lens in?

Deep Lens's product category is Clinical Trial Technology. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLAAANAE, Clinical Decision Support & Workflow Integration (EHR/oncology systems). Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBridge Bank Extends Venture Term Loan to Deep Lens, Inc.Bridge Bank has extended a venture term loan to Deep Lens, a Columbus, Ohio-based software company that provides an integrated cloud platform to accelerate clinical trial recruitment for cancer patients. Deep Lens CEO Simon Arkell described the financing as a vote of confidence in their business strategy, while Bridge Bank's Mark Breneman noted the company has developed a disruptive solution for rapid patient identification in clinical trials. Deep Lens is venture-backed by Northpond Ventures, Sierra Ventures, Rev1 Ventures, and Tamarind Hill.BioWorldDeep Lens clinical trial platform integrates cancer genetic data from any testDeep Lens Inc. integrated molecular data parsing and management technology into its Viper clinical trial screening and enrollment platform, enabling automated matching of patients with eligible genetic profiles to clinical trials. The Columbus, Ohio-based company licensed the proprietary technology from the University of Miami.HIT ConsultantDeep Lens Lands $14M to Scale AI-Driven Digital Pathology PlatformDeep Lens, an AI-driven digital pathology startup, raised $14 million in Series A funding led by Northpond Ventures. The round brings total funding to $17.5 million, including a $3.2 million seed round. The company will use the funds to expand AI and platform development and scale sales and marketing.Business Wire BlogDeep Lens Closes $14 Million Series A Financing to Further Advance Digital AI Pathology Platform for Clinical Trial RecruitmentDeep Lens closed a $14 million Series A financing led by Northpond Ventures, with existing investors participating. The company will use the funds to expand its AI platform and scale sales and marketing. Total funding to date is $17.5 million.VC News DailyDeep Lens Exits Stealth Mode with $3.2MDeep Lens exited stealth mode today by securing $3.2 million in seed financing led by Sierra Ventures, with participation from Rev1 Ventures and Tamarind Hill Fund. The company plans to use the funds to globally deploy its flagship AI-powered digital pathology platform, VIPER, which is currently available as a public beta.